Lab Reference Library / Fasting Glucose
Metabolic Health
Fasting Glucose
FBG · Fasting Blood Sugar · Serum GlucoseReference range, optimal functional medicine levels, and why fasting glucose is the most widely ordered metabolic test yet one of the last markers to become abnormal in insulin resistance, making it insufficient as a standalone metabolic screen.
Most SearchedMetabolic Marker
Standard Range70 to 99 mg/dL
FM Optimal72 to 85 mg/dL
Fasting RequiredYes (8 to 12 hrs)
Unitsmg/dL
← Back to Lab Reference Library
Category: Metabolic Health | Also known as: Fasting Blood Sugar, Serum Glucose, FBG | Sample: Serum; minimum 8 to 12 hour fast required
1. What This Test Measures
Fasting glucose measures the concentration of glucose in the bloodstream after a minimum 8 to 12 hour fast, during which no caloric intake has occurred. In the fasted state, blood glucose reflects two primary physiological processes: the liver's rate of glucose production (hepatic gluconeogenesis and glycogenolysis) and the rate of glucose uptake by peripheral tissues (primarily skeletal muscle and the brain).
In healthy metabolic function, fasting glucose is tightly regulated between approximately 70 and 85 mg/dL through the coordinated actions of insulin (which suppresses hepatic glucose output and promotes peripheral glucose uptake) and glucagon (which stimulates hepatic glucose release when glucose falls too low). This tight regulation means that fasting glucose remains remarkably stable in healthy individuals, making it an excellent reference marker when it does change.
The fundamental clinical limitation of fasting glucose is timing: it measures only what blood sugar is doing during the fasting state, after all the metabolic compensation mechanisms have had overnight to normalize. By the time fasting glucose rises meaningfully above 90 mg/dL, the underlying insulin resistance driving that elevation has typically been present for 10 to 15 years, during which fasting insulin was elevated while glucose remained normal through pancreatic compensation.
2. Why This Test Matters
- Essential metabolic baseline: fasting glucose is the foundation of any metabolic panel. Every calculation of HOMA-IR (the primary insulin resistance quantification tool) requires fasting glucose alongside fasting insulin. Without it, HOMA-IR cannot be calculated.
- Identifies impaired fasting glucose (IFG): conventional fasting glucose of 100 to 125 mg/dL (prediabetes range) and 126 mg/dL or above (diabetes) are important diagnostic thresholds. However, functional medicine recognizes that risk begins rising above 85 mg/dL, well within the conventional normal range of 70 to 99 mg/dL.
- Cardiovascular risk marker: the relationship between fasting glucose and cardiovascular disease risk is continuous, beginning below conventional diagnostic thresholds. A fasting glucose of 92 mg/dL carries meaningfully higher cardiovascular risk than a fasting glucose of 79 mg/dL, despite both being "normal" by conventional standards. Large prospective studies demonstrate linear risk increases from approximately 85 mg/dL upward.
- Tracks dietary and lifestyle intervention effectiveness: fasting glucose responds measurably to carbohydrate restriction, weight loss, exercise, and improved sleep, making it a reliable short-term feedback marker for metabolic interventions alongside HbA1c.
- Diabetes diagnosis: fasting glucose of 126 mg/dL or above on two separate occasions, or with classic symptoms on one occasion, confirms type 2 diabetes without requiring further testing.
- Context for HbA1c: while HbA1c reflects the 90-day average, fasting glucose reveals the baseline hepatic glucose output rate. A rising fasting glucose with stable HbA1c suggests worsening hepatic insulin resistance. Together they provide a more complete picture than either alone.
3. Standard Lab Reference Range
| Fasting Glucose | Conventional Classification |
|---|---|
| 70 to 99 mg/dL | Normal |
| 100 to 125 mg/dL | Prediabetes (Impaired Fasting Glucose) |
| 126 mg/dL or above | Diabetes (on two separate fasting occasions) |
| Below 70 mg/dL | Hypoglycemia: evaluate for excessive insulin, medication effects, or reactive hypoglycemia |
4. Optimal Functional Medicine Range
| Fasting Glucose | Functional Interpretation |
|---|---|
| 72 to 85 mg/dL | Optimal: excellent hepatic insulin sensitivity; lowest metabolic and cardiovascular risk |
| 85 to 90 mg/dL | Good: acceptable; monitor fasting insulin for compensatory hyperinsulinemia |
| 90 to 99 mg/dL | Borderline: within standard normal but risk rising; evaluate fasting insulin and HOMA-IR |
| 100 to 125 mg/dL | Prediabetes: significant risk; active intervention required; complete metabolic panel |
| 126 mg/dL or above | Diabetes: comprehensive treatment and monitoring protocol |
The 85 mg/dL threshold: multiple large studies including the Framingham Offspring Study and the ARIC study demonstrate that cardiovascular risk increases continuously above fasting glucose of approximately 85 mg/dL. The conventional normal range up to 99 mg/dL is not a risk-free zone; it spans a meaningful gradient of metabolic and cardiovascular risk that functional medicine addresses proactively.
5. The Metabolic Detection Gap: Why Fasting Glucose Alone Is Not Enough
The following clinical scenario illustrates why fasting glucose cannot be the sole metabolic screening test:
| Patient Profile | Fasting Glucose | Fasting Insulin | HOMA-IR | HbA1c | Actual Status |
|---|---|---|---|---|---|
| Healthy 35-year-old | 79 mg/dL | 4 µIU/mL | 0.78 | 5.1% | Excellent metabolic health |
| Early insulin resistance | 88 mg/dL | 16 µIU/mL | 3.47 | 5.4% | Significant IR; told "completely normal" on standard panel |
| Compensated prediabetes | 94 mg/dL | 22 µIU/mL | 5.10 | 5.6% | Advanced IR; standard panel reports all normal |
| Prediabetes | 107 mg/dL | 18 µIU/mL | 4.74 | 5.9% | Only now detectable on standard panel; 15 years into process |
6. Symptoms Associated With Abnormal Fasting Glucose
Elevated Fasting Glucose (Prediabetes and Above)
- Post-meal fatigue and energy crashes
- Carbohydrate and sugar cravings
- Difficulty losing weight
- Elevated blood pressure
- Increased thirst and urination (above 126 mg/dL)
- Brain fog and reduced mental clarity
- Blurred vision (higher glucose ranges)
- Skin tags and acanthosis nigricans
- Frequent infections and slow wound healing (diabetes range)
Low Fasting Glucose (Hypoglycemia)
- Shakiness, trembling, and sweating upon waking
- Anxiety and heart palpitations in the morning
- Inability to skip meals without significant symptoms
- Brain fog and difficulty concentrating that resolves with eating
- Reactive hypoglycemia pattern: symptoms 2 to 4 hours after meals
- In diabetic patients: insulin or medication excess requiring adjustment
- Rarely: insulinoma or adrenal insufficiency
7. What Causes Elevated Fasting Glucose
- Hepatic insulin resistance: the most common cause; when the liver does not respond adequately to insulin's glucose-suppression signal, it overproduces glucose overnight, raising fasting glucose even when post-meal glucose handling is still compensated
- Type 2 diabetes: combination of insulin resistance and progressive beta-cell dysfunction reduces the pancreatic insulin output needed to suppress overnight hepatic glucose production
- Chronic stress and elevated cortisol: cortisol directly stimulates hepatic gluconeogenesis; patients with high cortisol frequently have elevated fasting glucose even with adequate dietary carbohydrate restriction
- Poor sleep quality: even one night of poor sleep measurably impairs insulin sensitivity and raises fasting glucose the following morning; chronic sleep deprivation produces a consistent elevation
- Medications: corticosteroids, thiazide diuretics, atypical antipsychotics, and certain immunosuppressants raise fasting glucose through insulin resistance and hepatic glucose stimulation
- Cushing's syndrome: excess cortisol from adrenal or pituitary pathology produces significant fasting hyperglycemia alongside characteristic clinical features
- Dawn phenomenon: normal physiological rise in cortisol and growth hormone before waking stimulates hepatic glucose output; exaggerated in insulin-resistant individuals and people with diabetes
8. How to Improve This Marker
Nutrition
- Reduce total dietary carbohydrate and refined grain intake: the most direct intervention for lowering fasting glucose; hepatic overnight glucose production correlates with overall carbohydrate metabolic load
- Eliminate added sugars and high-fructose corn syrup: fructose uniquely promotes hepatic insulin resistance, the primary driver of elevated fasting glucose
- Eat dinner earlier: extending the overnight fast (finish eating by 7pm, draw blood at 8am) improves fasting glucose by extending hepatic glycogen depletion time
- Protein and healthy fat with every meal: reduces post-meal glucose spikes and stabilizes overnight glucose through satiety and reduced carbohydrate dependence
- Apple cider vinegar at dinner (1 to 2 tablespoons in water): consistent evidence for reducing next-morning fasting glucose by reducing overnight hepatic glucose production
Lifestyle
- Post-dinner walk: 10 to 15 minutes of walking after the evening meal significantly reduces next-morning fasting glucose by promoting muscle glucose disposal before overnight fasting begins
- Resistance training: the most durable lifestyle intervention for fasting glucose; increases skeletal muscle mass and GLUT4 transporter expression, improving insulin-stimulated glucose uptake over time
- Sleep optimization: 7 to 9 hours of quality sleep; poor sleep is one of the most reliable short-term drivers of elevated fasting glucose through cortisol and growth hormone effects
- Stress reduction: chronic cortisol elevation is a direct driver of hepatic gluconeogenesis; HRV biofeedback, breathwork, and adequate sleep reduce cortisol-driven fasting glucose elevation
- Weight loss: reducing visceral fat improves hepatic insulin sensitivity and reduces overnight glucose overproduction; a 5 to 10% body weight reduction reliably lowers fasting glucose
Targeted Support
- Berberine (500mg three times daily with meals): AMPK activator; reduces hepatic glucose production and improves peripheral insulin sensitivity; multiple RCTs show fasting glucose reductions of 10 to 25 mg/dL in prediabetic and diabetic patients
- Magnesium (300 to 400mg daily): improves insulin receptor function; deficiency is strongly associated with elevated fasting glucose and insulin resistance; supplementation consistently reduces fasting glucose in deficient patients
- Chromium picolinate (200 to 400mcg daily): potentiates insulin receptor signaling; evidence-based for modest fasting glucose reduction
- Alpha-lipoic acid (600mg daily): improves insulin sensitivity in muscle and reduces hepatic glucose output
- Medical options: metformin (reduces hepatic gluconeogenesis; first-line medication for prediabetes and type 2 diabetes; also raises adiponectin and has potential longevity benefits through AMPK activation); GLP-1 receptor agonists for significant weight and glucose reduction in appropriate candidates
9. Related Lab Tests
Fasting InsulinDetects IR Before Glucose Rises
→
HOMA-IRCalculated from Fasting Glucose + Insulin
→
HbA1c90-Day Glucose Average
→
TG/HDL RatioLipid Expression of Insulin Resistance
→
AdiponectinFalls Before Fasting Glucose Rises
→
Cortisol (AM)Cortisol Drives Hepatic Glucose Production
→
10. When Testing Is Recommended
- Always fast a minimum of 8 to 12 hours before blood draw; non-fasting glucose is not interpretable for metabolic assessment
- Annual screening for all adults; fasting glucose is a standard component of a comprehensive metabolic panel
- Always order alongside fasting insulin and calculate HOMA-IR; fasting glucose alone is insufficient for metabolic assessment
- Before and during dietary and lifestyle interventions; provides short-term feedback on effectiveness
- Family history of type 2 diabetes or metabolic syndrome
- Overweight or obesity with abdominal weight gain
- Monitoring medication effects on blood sugar (corticosteroids, atypical antipsychotics)
- Evaluation of hypoglycemia symptoms; fasting glucose drawn during symptomatic episode
11. Clinical Perspective
Clinical Perspective
Fasting glucose is the metabolic test everyone gets and the one that gives the false sense of security the longest. A patient can have a fasting glucose of 91 mg/dL and be told everything is fine for 12 consecutive years while their insulin is climbing from 8 to 12 to 16 to 20 µIU/mL, their waist is expanding, their TG/HDL ratio is deteriorating, and their adiponectin is dropping. When the glucose finally hits 102 and someone calls it prediabetes, they act like this is a new diagnosis. It is not a new diagnosis. It is the visible endpoint of a process we could have identified and interrupted a decade earlier with fasting insulin. I use fasting glucose as a necessary component of metabolic assessment, but it is the evidence of what already happened, not the early warning we need.
Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma
12. Frequently Asked Questions
What is the optimal fasting glucose level?
In functional medicine, optimal fasting glucose is 72 to 85 mg/dL. The conventional normal range allows up to 99 mg/dL, but research shows cardiovascular risk, Alzheimer's disease risk, and metabolic dysfunction begin rising continuously above approximately 85 mg/dL. A fasting glucose of 92 to 99 mg/dL is technically normal but represents a meaningfully different metabolic risk profile than a fasting glucose of 79 mg/dL.
What is the difference between fasting glucose and fasting insulin?
Fasting glucose measures blood sugar. Fasting insulin measures the hormone the pancreas produces to manage that blood sugar. In early insulin resistance, the pancreas compensates by producing more insulin to maintain normal blood glucose. Fasting glucose remains normal throughout this compensatory phase while fasting insulin is already elevated. Fasting insulin identifies insulin resistance 10 to 20 years before fasting glucose rises above the prediabetes threshold.
What fasting glucose level indicates prediabetes?
By conventional criteria, prediabetes is fasting glucose of 100 to 125 mg/dL. In functional medicine, any fasting glucose consistently above 90 to 95 mg/dL with concurrent elevated fasting insulin, elevated HOMA-IR, or elevated TG/HDL ratio represents clinically significant insulin resistance warranting dietary and lifestyle intervention, regardless of whether the conventional prediabetes label has been applied.
What causes elevated fasting glucose?
The most common cause is hepatic insulin resistance, where the liver overproduces glucose overnight because it does not respond adequately to insulin's glucose-suppression signal. Other causes include type 2 diabetes, stress and elevated cortisol (directly stimulates hepatic gluconeogenesis), poor sleep quality (one of the most reliable short-term drivers), medications (corticosteroids, thiazides, antipsychotics), and dawn phenomenon (physiological pre-waking cortisol and growth hormone surge).
Is fasting glucose enough to screen for metabolic disease?
No. Fasting glucose is necessary but insufficient for metabolic screening because it is one of the last markers to become abnormal in developing insulin resistance. A complete metabolic screen requires fasting insulin and HOMA-IR (to detect compensatory hyperinsulinemia before glucose rises), HbA1c (90-day glucose average), the TG/HDL ratio (lipid expression of insulin resistance), and adiponectin (earliest adipose tissue dysfunction marker). Together these provide a comprehensive picture that fasting glucose alone cannot.
Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.
Fasting glucose is the last metabolic marker to become abnormal. By then, 10 to 15 years of insulin resistance have passed.
A complete metabolic panel catches insulin resistance when there is still time to reverse it. Schedule a consultation for fasting insulin, HOMA-IR, and a full metabolic evaluation.
Schedule a ConsultationMedical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.